News
The OD Expert Group submitted its response to the Commission Public Consultation on the revision of EU rules on medicines for children and rare diseases, that took place between 7 May and 30 July. The response reflects the proposals of the final report of the OD Expert Group. In our response, we call for a […]
Posted on 2. August 2021
News
The launch event of the OD Expert Group took place on 11 June and was entitled “How to address the unmet needs of rare disease patients by transforming the European OMP landscape”. The experts discussed with audiences, policy makers and panellists compelling ideas for the next decade of rare disease policies in Europe. More information […]
Posted on 21. June 2021
Resources
The multidisciplinary European Expert Group on Orphan Drug Incentives has developed fourteen innovative proposals along the entire lifecycle of orphan drug development to address the huge unmet needs in rare diseases. The proposals range from basic research to patient access, considering the clinical development challenges, regulatory approval procedures and access mechanisms
Posted on 21. June 2021
News
The European Expert Group on Orphan Drug Incentives has officially launched! The below video offers a brief overview of the state of #rarediseases in Europe and introduces the Expert Group tasked with examining how to improve the situation. Our Knowledge Partner, Copenhagen Economics , has produced this videoclip to disseminate the Expert Group’s findings. https://www.linkedin.com/feed/update/urn:li:activity:6809115496554803200
Posted on 11. June 2021
Press Release
The multidisciplinary European Expert Group on Orphan Drug Incentives has developed fourteen innovative proposals along the entire lifecycle of orphan drug development to address the huge unmet needs in rare diseases. With over ninety percent of patients without a centrally approved treatment option, the need for innovation and research into orphan drugs is immense. Read […]
Posted on 11. June 2021
